Page last updated: 2024-11-07

phenylglucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Phenylglucuronide is a glucuronide conjugate of phenol. It is formed in the liver by the enzyme UDP-glucuronosyltransferase (UGT) and is a major route of detoxification for phenol. Phenylglucuronide is excreted in urine and feces. It is studied because it is an important biomarker for exposure to phenol. Phenylglucuronide is also used as a substrate for the study of UGT activity.'

Cross-References

ID SourceID
PubMed CID119239
CHEBI ID177778
SCHEMBL ID3224345
MeSH IDM0084480

Synonyms (10)

Synonym
16063-67-5
CHEBI:177778
phenyl d-glucopyranosiduronic acid
(2s,3s,4s,5r)-3,4,5-trihydroxy-6-phenoxyoxane-2-carboxylic acid
phenylglucuronide
d-glucopyranosiduronic acid, phenyl
SCHEMBL3224345
phenyl glucopyranosiduronic acid
DTXSID60936351
phenyl hexopyranosiduronic acid

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Saturation of benzene metabolism could limit the production of toxic species."( Hematotoxicity and concentration-dependent conjugation of phenol in mice following inhalation exposure to benzene.
Nerland, DE; Wells, MS, 1991
)
0.28

Dosage Studied

ExcerptRelevanceReference
" Of the total phenol in the aquarium water of goldfish exposed previously to phenol for 48 h, 41% was found to be phenylglucuronide when fish were placed in a phenol-free medium and were dosed hourly for 8 h with D-saccharic acid 1,4-lactone to inhibit beta-glucuronidase activity in the intestine."( Hydrolysis of the biliary glucuronic acid conjugate of phenol by the intestinal mucus/flora of goldfish (Carassius auratus).
Knights, B; Layiwola, PJ; Linnecar, DF, 1983
)
0.48
" The immersion dosing method employed for the experiment is discussed with relation to the natural habitat of the fish."( The biotransformation of [14C]phenol in some freshwater fish.
Layiwola, PJ; Linnecar, DF, 1981
)
0.26
" Dividing the dose-response curve data obtained with in vitro PBK-based reverse dosimetry, with the CSAF provided a dose-response curve that reflects the consequences of the interindividual variability in phenol kinetics for the developmental toxicity of phenol."( Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
Punt, A; Rietjens, IMCM; Spenkelink, B; Strikwold, M; Woutersen, RA, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
glycosideA glycosyl compound resulting from the attachment of a glycosyl group to a non-acyl group RO-, RS-, RSe-, etc. The bond between the glycosyl group and the non-acyl group is called a glycosidic bond. By extension, the terms N-glycosides and C-glycosides are used as class names for glycosylamines and for compounds having a glycosyl group attached to a hydrocarbyl group respectively. These terms are misnomers and should not be used. The preferred terms are glycosylamines and C-glycosyl compounds, respectively.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (61.11)18.7374
1990's4 (22.22)18.2507
2000's1 (5.56)29.6817
2010's2 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.13 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.12 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]